Yuichi Sumii to Cyclophosphamide
This is a "connection" page, showing publications Yuichi Sumii has written about Cyclophosphamide.
Connection Strength
0.395
-
Hematopoietic stem cell-derived Tregs are essential for maintaining favorable B cell lymphopoiesis following posttransplant cyclophosphamide. JCI Insight. 2023 04 24; 8(8).
Score: 0.171
-
Reduced dose of PTCy followed by adjuvant a-galactosylceramide enhances GVL effect without sacrificing GVHD suppression. Sci Rep. 2021 06 23; 11(1):13125.
Score: 0.151
-
Pretransplant nivolumab further enhanced Treg expansion after posttransplant cyclophosphamide; another aspect for immune tolerance by PTCy after nivolumab. Leukemia. 2021 03; 35(3):929-931.
Score: 0.037
-
Post-transplantation cyclophosphamide restores early B-cell lymphogenesis that suppresses subsequent chronic graft-versus-host disease. Bone Marrow Transplant. 2021 04; 56(4):956-959.
Score: 0.036